MRD (Minimal Residual Disease) refers to the state of a small amount of tumor cells remaining in the body after treatment of malignant tumors, which is the root cause of tumor recurrence. Accurate MRD detection is the basis for personalized precision medicine for patients.
The global MRD Detection market was valued at US$ 2314 million in 2023 and is anticipated to reach US$ 3481 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for MRD Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MRD Detection.
Report Scope
The MRD Detection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global MRD Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MRD Detection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Neoimmune
Labcorp Inc
F.Hoffmann-La Roche Ltd.
GuardantHealth
Sysmex Corporation
NeoGenomics Laboratories, Inc.
AdaptiveBiotechnologies Corporation
ArcherDX, Inc.
Asuragen Inc.
Arup Laboratories Inc.
Bio-Rad Laboratories
Opko Health
Quest Diagnostics
ICON plc
Cergentis B.V.
Segment by Type
Flow Cytometer
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Segment by Application
Scientific Research Unit
Medical School
CDC
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of MRD Detection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of MRD Detection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 MRD Detection Market Overview
1.1 Product Overview and Scope of MRD Detection
1.2 MRD Detection Segment by Type
1.2.1 Global MRD Detection Market Value Comparison by Type (2024-2030)
1.2.2 Flow Cytometer
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Next Generation Sequencing (NGS)
1.3 MRD Detection Segment by Application
1.3.1 Global MRD Detection Market Value by Application: (2024-2030)
1.3.2 Scientific Research Unit
1.3.3 Medical School
1.3.4 CDC
1.3.5 Other
1.4 Global MRD Detection Market Size Estimates and Forecasts
1.4.1 Global MRD Detection Revenue 2019-2030
1.4.2 Global MRD Detection Sales 2019-2030
1.4.3 Global MRD Detection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 MRD Detection Market Competition by Manufacturers
2.1 Global MRD Detection Sales Market Share by Manufacturers (2019-2024)
2.2 Global MRD Detection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global MRD Detection Average Price by Manufacturers (2019-2024)
2.4 Global MRD Detection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of MRD Detection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of MRD Detection, Product Type & Application
2.7 MRD Detection Market Competitive Situation and Trends
2.7.1 MRD Detection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest MRD Detection Players Market Share by Revenue
2.7.3 Global MRD Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 MRD Detection Retrospective Market Scenario by Region
3.1 Global MRD Detection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global MRD Detection Global MRD Detection Sales by Region: 2019-2030
3.2.1 Global MRD Detection Sales by Region: 2019-2024
3.2.2 Global MRD Detection Sales by Region: 2025-2030
3.3 Global MRD Detection Global MRD Detection Revenue by Region: 2019-2030
3.3.1 Global MRD Detection Revenue by Region: 2019-2024
3.3.2 Global MRD Detection Revenue by Region: 2025-2030
3.4 North America MRD Detection Market Facts & Figures by Country
3.4.1 North America MRD Detection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America MRD Detection Sales by Country (2019-2030)
3.4.3 North America MRD Detection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe MRD Detection Market Facts & Figures by Country
3.5.1 Europe MRD Detection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe MRD Detection Sales by Country (2019-2030)
3.5.3 Europe MRD Detection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific MRD Detection Market Facts & Figures by Country
3.6.1 Asia Pacific MRD Detection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific MRD Detection Sales by Country (2019-2030)
3.6.3 Asia Pacific MRD Detection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America MRD Detection Market Facts & Figures by Country
3.7.1 Latin America MRD Detection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America MRD Detection Sales by Country (2019-2030)
3.7.3 Latin America MRD Detection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa MRD Detection Market Facts & Figures by Country
3.8.1 Middle East and Africa MRD Detection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa MRD Detection Sales by Country (2019-2030)
3.8.3 Middle East and Africa MRD Detection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global MRD Detection Sales by Type (2019-2030)
4.1.1 Global MRD Detection Sales by Type (2019-2024)
4.1.2 Global MRD Detection Sales by Type (2025-2030)
4.1.3 Global MRD Detection Sales Market Share by Type (2019-2030)
4.2 Global MRD Detection Revenue by Type (2019-2030)
4.2.1 Global MRD Detection Revenue by Type (2019-2024)
4.2.2 Global MRD Detection Revenue by Type (2025-2030)
4.2.3 Global MRD Detection Revenue Market Share by Type (2019-2030)
4.3 Global MRD Detection Price by Type (2019-2030)
5 Segment by Application
5.1 Global MRD Detection Sales by Application (2019-2030)
5.1.1 Global MRD Detection Sales by Application (2019-2024)
5.1.2 Global MRD Detection Sales by Application (2025-2030)
5.1.3 Global MRD Detection Sales Market Share by Application (2019-2030)
5.2 Global MRD Detection Revenue by Application (2019-2030)
5.2.1 Global MRD Detection Revenue by Application (2019-2024)
5.2.2 Global MRD Detection Revenue by Application (2025-2030)
5.2.3 Global MRD Detection Revenue Market Share by Application (2019-2030)
5.3 Global MRD Detection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Neoimmune
6.1.1 Neoimmune Corporation Information
6.1.2 Neoimmune Description and Business Overview
6.1.3 Neoimmune MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Neoimmune MRD Detection Product Portfolio
6.1.5 Neoimmune Recent Developments/Updates
6.2 Labcorp Inc
6.2.1 Labcorp Inc Corporation Information
6.2.2 Labcorp Inc Description and Business Overview
6.2.3 Labcorp Inc MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Labcorp Inc MRD Detection Product Portfolio
6.2.5 Labcorp Inc Recent Developments/Updates
6.3 F.Hoffmann-La Roche Ltd.
6.3.1 F.Hoffmann-La Roche Ltd. Corporation Information
6.3.2 F.Hoffmann-La Roche Ltd. Description and Business Overview
6.3.3 F.Hoffmann-La Roche Ltd. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 F.Hoffmann-La Roche Ltd. MRD Detection Product Portfolio
6.3.5 F.Hoffmann-La Roche Ltd. Recent Developments/Updates
6.4 GuardantHealth
6.4.1 GuardantHealth Corporation Information
6.4.2 GuardantHealth Description and Business Overview
6.4.3 GuardantHealth MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GuardantHealth MRD Detection Product Portfolio
6.4.5 GuardantHealth Recent Developments/Updates
6.5 Sysmex Corporation
6.5.1 Sysmex Corporation Corporation Information
6.5.2 Sysmex Corporation Description and Business Overview
6.5.3 Sysmex Corporation MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sysmex Corporation MRD Detection Product Portfolio
6.5.5 Sysmex Corporation Recent Developments/Updates
6.6 NeoGenomics Laboratories, Inc.
6.6.1 NeoGenomics Laboratories, Inc. Corporation Information
6.6.2 NeoGenomics Laboratories, Inc. Description and Business Overview
6.6.3 NeoGenomics Laboratories, Inc. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NeoGenomics Laboratories, Inc. MRD Detection Product Portfolio
6.6.5 NeoGenomics Laboratories, Inc. Recent Developments/Updates
6.7 AdaptiveBiotechnologies Corporation
6.6.1 AdaptiveBiotechnologies Corporation Corporation Information
6.6.2 AdaptiveBiotechnologies Corporation Description and Business Overview
6.6.3 AdaptiveBiotechnologies Corporation MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AdaptiveBiotechnologies Corporation MRD Detection Product Portfolio
6.7.5 AdaptiveBiotechnologies Corporation Recent Developments/Updates
6.8 ArcherDX, Inc.
6.8.1 ArcherDX, Inc. Corporation Information
6.8.2 ArcherDX, Inc. Description and Business Overview
6.8.3 ArcherDX, Inc. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ArcherDX, Inc. MRD Detection Product Portfolio
6.8.5 ArcherDX, Inc. Recent Developments/Updates
6.9 Asuragen Inc.
6.9.1 Asuragen Inc. Corporation Information
6.9.2 Asuragen Inc. Description and Business Overview
6.9.3 Asuragen Inc. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Asuragen Inc. MRD Detection Product Portfolio
6.9.5 Asuragen Inc. Recent Developments/Updates
6.10 Arup Laboratories Inc.
6.10.1 Arup Laboratories Inc. Corporation Information
6.10.2 Arup Laboratories Inc. Description and Business Overview
6.10.3 Arup Laboratories Inc. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Arup Laboratories Inc. MRD Detection Product Portfolio
6.10.5 Arup Laboratories Inc. Recent Developments/Updates
6.11 Bio-Rad Laboratories
6.11.1 Bio-Rad Laboratories Corporation Information
6.11.2 Bio-Rad Laboratories MRD Detection Description and Business Overview
6.11.3 Bio-Rad Laboratories MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bio-Rad Laboratories MRD Detection Product Portfolio
6.11.5 Bio-Rad Laboratories Recent Developments/Updates
6.12 Opko Health
6.12.1 Opko Health Corporation Information
6.12.2 Opko Health MRD Detection Description and Business Overview
6.12.3 Opko Health MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Opko Health MRD Detection Product Portfolio
6.12.5 Opko Health Recent Developments/Updates
6.13 Quest Diagnostics
6.13.1 Quest Diagnostics Corporation Information
6.13.2 Quest Diagnostics MRD Detection Description and Business Overview
6.13.3 Quest Diagnostics MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Quest Diagnostics MRD Detection Product Portfolio
6.13.5 Quest Diagnostics Recent Developments/Updates
6.14 ICON plc
6.14.1 ICON plc Corporation Information
6.14.2 ICON plc MRD Detection Description and Business Overview
6.14.3 ICON plc MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ICON plc MRD Detection Product Portfolio
6.14.5 ICON plc Recent Developments/Updates
6.15 Cergentis B.V.
6.15.1 Cergentis B.V. Corporation Information
6.15.2 Cergentis B.V. MRD Detection Description and Business Overview
6.15.3 Cergentis B.V. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Cergentis B.V. MRD Detection Product Portfolio
6.15.5 Cergentis B.V. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 MRD Detection Industry Chain Analysis
7.2 MRD Detection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 MRD Detection Production Mode & Process
7.4 MRD Detection Sales and Marketing
7.4.1 MRD Detection Sales Channels
7.4.2 MRD Detection Distributors
7.5 MRD Detection Customers
8 MRD Detection Market Dynamics
8.1 MRD Detection Industry Trends
8.2 MRD Detection Market Drivers
8.3 MRD Detection Market Challenges
8.4 MRD Detection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Neoimmune
Labcorp Inc
F.Hoffmann-La Roche Ltd.
GuardantHealth
Sysmex Corporation
NeoGenomics Laboratories, Inc.
AdaptiveBiotechnologies Corporation
ArcherDX, Inc.
Asuragen Inc.
Arup Laboratories Inc.
Bio-Rad Laboratories
Opko Health
Quest Diagnostics
ICON plc
Cergentis B.V.
听
听
*If Applicable.
